Dolby Laboratories Reports Third Quarter Fiscal 2008 Results

Dolby Laboratories, Inc. (NYSE:DLB) today announced the Company's financial results for its third quarter of fiscal 2008.

For the third quarter, Dolby reported total revenue of $154.3 million, compared to $119.6 million for the third quarter of fiscal 2007, an increase of 29 percent. Third quarter net income was $46.4 million, or $0.40 per diluted share, compared to $29.7 million, or $0.26 per diluted share, for the third quarter of fiscal 2007.

Net income for the third quarter of fiscal 2008 reflects stock-based compensation expense of $5.6 million compared to $5.1 million for the third quarter of fiscal 2007. Net income for the third quarter of fiscal 2008 also reflects charges related to the amortization of intangibles of $3.0 million compared to $1.0 million for the third quarter of fiscal 2007.

"During the quarter, we experienced strong financial results while continuing to make progress in key initiatives such as PC Entertainment Experience and Dolby Mobile, said Bill Jasper, President and Chief Executive Officer, Dolby Laboratories. Earlier this week, LG, a global technology and design leader in mobile communications, announced it would introduce high-end multimedia handsets with Dolby Mobile by the end of calendar year 2008.

Guidance

Dolby now expects fiscal 2008 revenue to be $605 million to $625 million. Net income for fiscal 2008 is now expected to be $181 million to $190 million. Earnings per diluted share is now expected to be $1.57 to $1.65. While under FAS 123R, stock-based compensation expense may vary based on factors such as stock price or volatility, Dolby now expects stock-based compensation expense for fiscal 2008 to be approximately $23 million. In addition, Dolby continues to expect charges related to the amortization of intangibles for fiscal 2008 to be approximately $13 million.

The Company's Conference Call Information

Members of Dolby management will lead a conference call open to all interested parties to discuss Dolby Laboratories Q3 fiscal 2008 financial results at 2:00 p.m. PT/5:00 p.m. ET, Thursday, July 31, 2008.

Access to the teleconference will be available over the Internet from http://investor.dolby.com/medialist.cfm or by dialing 1-888-228-5281. International callers can access the conference call at 1-913-312-1423.

A replay of the call will be available beginning at 5:00 p.m. PT on July 31, 2008 until 9:00 p.m. PT on August 7, 2008; dial 1-888-203-1112 (international callers can access the replay by dialing 1-719-457-0820) and enter confirmation code 8298423. An archived version of the teleconference will also be available on Dolby Laboratories website, www.dolby.com.

Forward-Looking Statements

Certain statements in this press release, including statements relating to Dolby's expectations regarding revenue, net income, earnings per diluted share, stock-based compensation expense, and charges relating to the amortization of intangibles, for the fiscal year ending September 26, 2008, Dolbys continued progress on key initiatives such as PC Entertainment Experience and Dolby® Mobile, and the timing and availability of LG handsets with Dolby Mobile are forward-looking statements that are subject to risks and uncertainties. These forward-looking statements are based on managements current expectations, and as a result of certain risks and uncertainties actual results may differ materially from those projected. The following important factors, without limitation, could cause actual results to differ materially from those in the forward-looking statements: risks associated with trends in the markets in which Dolby operates, including trends related to DVD and Blu-ray DVD, broadcast, personal computer, gaming, mobile, or portable device markets, and trends relating to the development of additional and newer markets for Dolby technologies; the timing and effects of economic downturns in the United States and abroad; pricing pressures; the risk that LG may not ship handsets with Dolby Mobile by calendar year end or at all; the timing of Dolby's receipt of royalty reports and/or payments from its licensees; Dolbys accuracy of calculation of royalties due to its licensors; Dolbys ability to develop, maintain, and strengthen relationships with industry participants; Dolbys ability to develop and deliver innovative technologies in response to new and growing markets in the entertainment industry; competitive risks; risks associated with conducting business in China and other countries, including countries that have historically limited recognition and enforcement of intellectual property and contractual rights; risks associated with the motion picture industry generally; the development and growth of the market for digital cinema and digital 3D and Dolbys ability to successfully penetrate this market; Dolbys ability to expand its business generally, and to expand its business beyond sound technologies to other technologies related to digital entertainment delivery, including by acquiring and successfully integrating businesses or technologies; and other risks detailed in Dolbys Securities and Exchange Commission filings and reports, including the risks identified under the section captioned Risk Factors in its most recent Quarterly Report on Form 10-Q. Dolby disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.

About Dolby Laboratories

Dolby Laboratories (NYSE: DLB) is the global leader in technologies that are essential elements in the best entertainment experiences. Founded in 1965 and best known for high-quality audio and surround sound, Dolby innovations enrich entertainment at the movies, at home, or on the go. Visit www.dolby.com for more information.

Dolby and the double-D symbol are registered trademarks of Dolby Laboratories. S08/20185 DLB-F

DOLBY LABORATORIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Fiscal Quarter EndedFiscal Year-to-Date Ended
June 29, 2007June 27, 2008June 29, 2007June 27, 2008
(unaudited)
(in thousands, except per share amounts)
Revenue:
Licensing $ 94,795 $ 127,558 $ 283,812 $ 399,607
Product sales 17,191 18,060 47,870 53,698
Services 7,627 8,699 21,383 23,796
Total revenue 119,613 154,317 353,065 477,101
Cost of revenue:
Cost of licensing 8,478 3,361 26,287 12,179

Cost of product sales(1)

8,119 9,461 24,519 29,649

Cost of services(1)

2,963 3,194 8,470 9,400
Total cost of revenue 19,560 16,016 59,276 51,228
Gross margin 100,053 138,301 293,789 425,873
Operating expenses:

Selling, general and administrative(1)

48,430 54,979 128,266 161,275

Research and development(1)

11,854 15,366 31,650 44,998
Gain on settlements (350 ) (250 ) (1,850 ) (499 )
Total operating expenses 59,934 70,095 158,066 205,774
Operating income 40,119 68,206 135,723 220,099
Other income, net 5,759 2,661 17,118 10,269
Income before provision for income taxes and controlling interest 45,878 70,867 152,841 230,368
Provision for income taxes (15,839 ) (24,117 ) (53,067 ) (78,516 )
Income before controlling interest 30,039 46,750 99,774 151,852
Controlling interest in net income, net of tax (354 ) (302 ) (1,101 ) (953 )
Net income$29,685$46,448$98,673$150,899
Basic earnings per share $ 0.27 $ 0.42 $ 0.91 $ 1.36
Diluted earnings per share $ 0.26 $ 0.40 $ 0.87 $ 1.32
Weighted-average shares outstanding (basic) 109,692 111,844 108,898 111,209
Weighted-average shares outstanding (diluted) 113,696 114,875 113,389 114,672
(1) Stock-based compensation included above was classified as follows:
Cost of product sales $ 269 $ 167 $ 679 $ 670
Cost of services 39 48 107 126
Selling, general and administrative 3,838 4,262 11,459 13,157
Research and development 993 1,158 2,512 3,277

DOLBY LABORATORIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
September 28, 2007

   June 27, 2008   

(unaudited)
(in thousands)

ASSETS
Current assets:
Cash and cash equivalents $ 368,467 $ 369,907
Short-term investments 231,217 49,552
Accounts receivable, net 28,165 45,933
Inventories 14,883 22,000
Deferred income taxes 73,686 85,576
Prepaid expenses and other current assets 17,000 47,018
Total current assets 733,418 619,986
Property, plant and equipment, net 85,552 85,775
Intangible assets, net 35,389 90,751
Goodwill 39,364 273,552
Long-term investments 73,224 179,538
Long-term deferred income taxes 12,393 12,817
Other assets 12,357 13,188
Total assets$991,697$1,275,607
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable and accrued liabilities $ 119,068 $ 143,312
Income taxes payable 9,051 2,833
Current portion of long-term debt 1,563 1,607
Deferred revenue 13,522 30,894
Total current liabilities 143,204 178,646
Long-term debt 9,691 8,408
Long-term deferred revenue 5,073 6,069
Deferred income tax liability - 18,985
Other non-current liabilities 14,294 29,323
Total liabilities 172,262 241,431
Controlling interest 22,279 22,699
Stockholders' equity:
Class A common stock 49 52
Class B common stock 61 61
Additional paid-in capital 375,830 424,502
Retained earnings 409,749 560,936
Accumulated other comprehensive income 11,467 25,926
Total stockholders' equity 797,156 1,011,477
Total liabilities and stockholders' equity$991,697$1,275,607

Contacts:

Dolby Laboratories
Investors:
Alex Hughes, 415-645-4572
investor@dolby.com
Media:
Jeanne Alford, 415-645-5000
news@dolby.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.